Trial Profile
Menopause Strategies: Finding Lasting Answers for Symptoms and Health: Efficacy of a Selective Serotonin Reuptake Inhibitor (SSRI) for Menopausal Symptoms in Midlife Women.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Hot flashes; Menopausal syndrome
- Focus Therapeutic Use
- Acronyms MsFLASH-01
- 01 Mar 2012 Results of the sexual function analysis published in Obstetrics and Gynecology.
- 24 Sep 2011 Results assessing sleep quality and insomnia symptoms presented at the 22nd Annual Meeting of the North American Menopause Society.
- 09 Oct 2010 Results were presented at the 21st Annual Meeting of the North American Menopause Society.